health express semaglutide Ozempic may slow down kidney disease: Why Novo Nordisk's new trial may treat other conditions | Health and Wellness News Semaglutide - Wikipedia

Its primarily approved for chronic weight management in adults with obesity or who are overweight and have at least one weight-related condition, like diabetes, high blood pressure or a risk of cardiovascular events

Additionally, The New England Journal of Medicine published a clinical study in 2023 demonstrating how semaglutide reduced the risk of cardiovascular disease

The New Look: The Inverted Pyramid To understand how big this change is, you have to look at heart healthure

A 2026 systematic review and meta-analysis in Clinical Endocrinology pooled 5 randomized controlled trials of short-term, low-dose spironolactone in PCOS hyperandrogenic symptoms and found a meaningful reduction in modified Ferriman-Gallwey hirsutism scores compared to placebo or alternative anti-androgens